Artificial heart trial aims to keep patients alive until transplant
NCT ID NCT05474092
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing the Aeson total artificial heart, a device that replaces both heart ventricles, in 95 people with severe heart failure. The goal is to confirm that the device works safely and effectively as a bridge to heart transplant. Researchers will measure survival rates and quality of life before transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Aeson Total Artificial Heart (implantable device)
- What this could lead to
- If successful, this device could provide a reliable temporary replacement heart for people waiting for a transplant, improving survival and quality of life.
- What could go wrong
- This is a post-market study, so the device is already approved. However, risks include surgical complications, device malfunction, or infection. The trial is relatively small (95 participants).
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
HZ Dresden
RECRUITINGDresden, 01307, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?
- Can slow breathing soothe a failing heart?
- Can shedding pounds reboot the Heart's exercise engine?